Wenyin Shi MD

Clinical Trials

• Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases Start of enrollment: 2005 Oct 01

  Completed

  Phase 1

• Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases Start of enrollment: 2009 Mar 01

  Completed

  Phase 1

• A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies Start of enrollment: 2008 Apr 10

  Completed

  Phase 2

• Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors Start of enrollment: 2012 May 01

  Terminated

  Phase 1

• TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma Start of enrollment: 2007 Oct 01

  Completed

• High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma Start of enrollment: 2012 Jun 01

  Terminated

  Phase 1

• A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Start of enrollment: 2011 Aug 04

  Completed

  Phase 2

• Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer Start of enrollment: 2011 Sep 22

  Completed

  Phase 1

• High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2012 Oct 04

  Active, not recruiting

  Phase 1

• Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09

  Completed

  Phase 1

• Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy Start of enrollment: 2013 Mar 08

  Completed

  Not Applicable

• Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor Start of enrollment: 2013 Nov 04

  Completed

  Phase 2

• Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

  Withdrawn

  Phase 1

• Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11

  Completed

• Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30

  Completed

  Phase 1

• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22

  Completed

• Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma Start of enrollment: 2018 May 04

  Completed

  Early Phase 1

• Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma Start of enrollment: 2019 Aug 09

  Completed

  Phase 2

• Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery Start of enrollment: 2017 Feb 21

  RECRUITING

  NA

  Roles: Contact, Principal Investigator

• Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma Start of enrollment: 2017 Jul 17

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Join now to see all